Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
Cuisset T, Hamilos M, Sarma J, Sarno G, Wyffels E, Vanderheyden M, Barbato E, Bartunek J, De Bruyne B, Wijns W. Cuisset T, et al. Among authors: hamilos m. Am J Cardiol. 2008 Jun 15;101(12):1700-3. doi: 10.1016/j.amjcard.2008.02.054. Epub 2008 Apr 18. Am J Cardiol. 2008. PMID: 18549843
Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
Muller O, Hamilos M, Bartunek J, Ulrichts H, Mangiacapra F, Holz JB, Ntalianis A, Trana C, Dierickx K, Vercruysse K, De Bruyne B, Wijns W, Barbato E. Muller O, et al. Among authors: hamilos m. Am J Cardiol. 2010 Feb 1;105(3):333-8. doi: 10.1016/j.amjcard.2009.09.033. Epub 2009 Dec 22. Am J Cardiol. 2010. PMID: 20102944
Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
Alexopoulos D, Goudevenos JA, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Parissis H, Ntalas IV, Angelidis C, Petousis S, Vavuranakis M, Hahalis G, Stefanadis C; GRAPE Investigators. Alexopoulos D, et al. Among authors: hamilos m. Int J Cardiol. 2013 Oct 15;168(6):5329-35. doi: 10.1016/j.ijcard.2013.08.007. Epub 2013 Aug 15. Int J Cardiol. 2013. PMID: 23978364 Clinical Trial.
Contraindications/special warnings and precautions for use of contemporary oral antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Vavuranakis M, Davlouros P, Ntalas I, Angelidis C, Hahalis G, Triposkiadis F, Vardas P, Stefanadis C, Goudevenos JA; GRAPE Investigators. Alexopoulos D, et al. Among authors: hamilos m. Circ J. 2014;78(1):180-7. doi: 10.1253/circj.cj-13-0795. Epub 2013 Nov 2. Circ J. 2014. PMID: 24189502 Free article. Clinical Trial.
In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prevalence, predictors and short-term outcome.
Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Angelidis C, Petousis S, Stakos D, Parissis H, Vavouranakis M, Davlouros P, Goudevenos J, Stefanadis C. Alexopoulos D, et al. Among authors: hamilos m. Am Heart J. 2014 Jan;167(1):68-76.e2. doi: 10.1016/j.ahj.2013.10.010. Epub 2013 Oct 22. Am Heart J. 2014. PMID: 24332144
Bivalirudin use and one-month outcome in the context of contemporary antiplatelet treatment: insights from the Greek Antiplatelet Registry.
Alexopoulos D, Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Karayannis G, Angelidis C, Stavrou K, Vavuranakis M, Goudevenos JA, Stefanadis C; GRAPE Investigators. Alexopoulos D, et al. Among authors: hamilos m. Cardiovasc Ther. 2014 Jun;32(3):120-6. doi: 10.1111/1755-5922.12068. Cardiovasc Ther. 2014. PMID: 24512682 Free article.
In-hospital bleeding events in acute coronary syndrome patients undergoing percutaneous coronary intervention in the era of novel P2Y12 inhibitors: insights from the GReek AntiPlatelet rEgistry-GRAPE.
Xanthopoulou I, Deftereos S, Sitafidis G, Kanakakis I, Hamilos M, Karayannis G, Angelidis C, Stavrou K, Vavuranakis M, Goudevenos JA, Stefanadis C, Alexopoulos D. Xanthopoulou I, et al. Among authors: hamilos m. Int J Cardiol. 2014 Jun 1;174(1):160-2. doi: 10.1016/j.ijcard.2014.03.161. Epub 2014 Mar 28. Int J Cardiol. 2014. PMID: 24726352 No abstract available.
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.
Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, Agostoni P, Appelman Y, Arslan F, Barbato E, Chen SL, Di Serafino L, Domínguez-Franco AJ, Dupouy P, Esen AM, Esen OB, Hamilos M, Iwasaki K, Jensen LO, Jiménez-Navarro MF, Katritsis DG, Kocaman SA, Koo BK, López-Palop R, Lorin JD, Miller LH, Muller O, Nam CW, Oud N, Puymirat E, Rieber J, Rioufol G, Rodés-Cabau J, Sedlis SP, Takeishi Y, Tonino PA, Van Belle E, Verna E, Werner GS, Fearon WF, Pijls NH, De Bruyne B, Gould KL. Johnson NP, et al. Among authors: hamilos m. J Am Coll Cardiol. 2014 Oct 21;64(16):1641-54. doi: 10.1016/j.jacc.2014.07.973. J Am Coll Cardiol. 2014. PMID: 25323250 Free article.
99 results